J Delahousse

Institut Gustave Roussy — France

Medicine · Health Sciences

10h-index375citations80works8.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(4), Cancer Treatment and Pharmacology(4), Chemotherapy-induced organ toxicity mitigation(4), Amoebic Infections and Treatments(4), Cancer Immunotherapy and Biomarkers(3)

Publications80 total

Sex differences in the pharmacokinetics of anticancer drugs: a systematic review
ESMO Open·2024· 22 citedOpen Access
Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network
Journal of Endocrinological Investigation·2024· 2 citedOpen Access
“Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities”
Cancer Letters·2024· 13 cited
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors
Journal for ImmunoTherapy of Cancer·2024· 2 citedOpen Access
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review
Journal of Pain and Symptom Management·2024· 3 citedOpen Access
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
Frontiers in Immunology·2023· 17 citedOpen Access
Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network
2023· 1 citedOpen Access
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
2023· 1 citedOpen Access
Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions
Expert Opinion on Drug Metabolism & Toxicology·2023· 6 cited
Abstract 1884: HFB9-2, a novel Galectin 9 neutralizing antibody for the treatment of AML and other cancers
Cancer Research·2021· 1 cited
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer
Cancers·2020· 5 citedOpen Access
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study
Leukemia & lymphoma/Leukemia and lymphoma·2020· 5 cited
Valeurs pronostiques des mesures précoces de mitotanémie plasmatique totale et libre ou au sein des fractions lipoprotéiques dans le corticosurrénalome métastatique : une étude prospective du réseau Comète-Cancer
Annales d Endocrinologie·2020
607P Prognostic value of early total, free and bound to lipoprotein fractions plasma mitotane measurements in advanced adrenocortical carcinoma at the time of mitotane initiation: A prospective study of the ENDOCAN-COMETE-cancer network
Annals of Oncology·2020· 1 cited
Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects
Journal for ImmunoTherapy of Cancer·2020· 6 citedOpen Access
Pharmacokinetics/Pharmacodynamic (PK/PD) relationship of therapeutic monoclonal antibodies used in oncology: what's new?
European Journal of Cancer·2020· 12 cited
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies
European Journal of Cancer·2020· 75 cited
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers
European Journal of Cancer·2020· 53 cited
From ifosfamide to geranyloxy-ifosfamide : pharmacomodulation to target and modulate immunity
HAL (Le Centre pour la Communication Scientifique Directe)·2019Open Access
De l’ifosfamide au géranyloxy-ifosfamide : pharmacomodulation pour cibler et moduler l’immunité
ZooKeys·2019Open Access
page 1 of 4Next →

Frequent Co-authors

Angélo Paci(24), Sophie Broutin(11), Nathalie Chaput(7), Olivier Mir(6), Véronique Saada(6), David Combarel(5), Aude Desnoyer(4), Ludovic Lacroix(4), Stéphane de Botton(4), Charles Skarbek(3), Christophe Willekens(3), Aline Renneville(3), Jean‐Baptiste Micol(3), Vianney Poinsignon(3), Cyril Quivoron(3), Claude Preudhomme(3), Virginie Penard‐Lacronique(3), Jean‐Luc Perfettini(3), G Charmot(3), Arthur Géraud(3)